Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson’s disease

BACKGROUND: The early clinical trials using fetal ventral mesencephalic (VM) allografts in Parkinson’s disease (PD) patients have shown efficacy (albeit not in all cases) and have paved the way for further development of cell replacement therapy strategies in PD. The preclinical work that led to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamburrino, Anna, Churchill, Madeline J., Wan, Oi W., Colino-Sanguino, Yolanda, Ippolito, Rossana, Bergstrand, Sofie, Wolf, Daniel A., Herz, Niculin J., Sconce, Michelle D., Björklund, Anders, Meshul, Charles K., Decressac, Mickael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678733/
https://www.ncbi.nlm.nih.gov/pubmed/26666562
http://dx.doi.org/10.1186/s40478-015-0263-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678733/
https://www.ncbi.nlm.nih.gov/pubmed/26666562
http://dx.doi.org/10.1186/s40478-015-0263-6

Ejemplares similares